Buchumschlag

Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology

Fuente: arXiv

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sun, Hao, Lin, Hsin-Yu, Tu, Jieqi, Ananthakrishnan, Revathi, Kim, Eunhee
Format:	Preprint
Veröffentlicht:	2024
Schlagworte:	Methodology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
von: Sun, Hao, et al.
Veröffentlicht: (2025)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
von: Lee, Kyong Ju, et al.
Veröffentlicht: (2025)

A Likelihood Perspective on Dose-Finding Study Designs in Oncology
von: Zhang, Zhiwei
Veröffentlicht: (2023)

Dual-criterion Dose Finding Designs Based on Dose-Limiting Toxicity and Tolerability
von: Yang, Yunlong, et al.
Veröffentlicht: (2024)

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
von: Hao Sun, et al.
Veröffentlicht: (2024)

Estimands for Early Phase Dose Optimization Trials in Oncology
von: Mukherjee, Ayon, et al.
Veröffentlicht: (2025)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
von: Chen, Yuxuan, et al.
Veröffentlicht: (2026)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
von: Li, Yuhan, et al.
Veröffentlicht: (2024)

BOP2-TE: Bayesian Optimal Phase 2 Design for Jointly Monitoring Efficacy and Toxicity with Application to Dose Optimization
von: Chen, Kai, et al.
Veröffentlicht: (2024)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
von: Hall, Andrew, et al.
Veröffentlicht: (2025)

LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
von: Sverdlov, Oleksandr, et al.
Veröffentlicht: (2025)

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity
von: Chen, Kai, et al.
Veröffentlicht: (2025)

Estimands for Randomized Discontinuation Designs in Oncology
von: Mukherjee, Ayon, et al.
Veröffentlicht: (2025)

Bayesian Optimization for Identification of Optimal Biological Dose Combinations in Personalized Dose-Finding Trials
von: Willard, James, et al.
Veröffentlicht: (2024)

An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
von: Zehetmayer, Sonja, et al.
Veröffentlicht: (2026)

Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies
von: Willard, James, et al.
Veröffentlicht: (2023)

A Comparative Evaluation of Bayesian Model-Assisted Two-Stage Designs for Phase I/II Clinical Trials
von: Sun, Hao, et al.
Veröffentlicht: (2025)

Toxicity Monitoring Rule for a Two-Cohort Phase II Clinical Trial with Bivariate Beta Prior
von: Wang, Yu, et al.
Veröffentlicht: (2026)

Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
von: Amevor, Robert, et al.
Veröffentlicht: (2026)

Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
von: DAngelo, Gina, et al.
Veröffentlicht: (2025)

ROSE: Randomized Optimal Selection Design for Dose Optimization
von: Wang, Shuqi, et al.
Veröffentlicht: (2025)

Likelihood-based Nonparametric Receiver Operating Characteristic Curve Analysis in the Presence of Imperfect Reference Standard
von: Sun, Yifan, et al.
Veröffentlicht: (2025)

Building a Standardised Statistical Reporting Toolbox in an Academic Oncology Clinical Trials Unit: The grstat R Package
von: Chaltiel, Dan, et al.
Veröffentlicht: (2026)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
von: Gu, Xuemin, et al.
Veröffentlicht: (2026)

A Two-Step Test to Identify Zero-Inflated Biomarkers in Early-Phase Clinical Trials
von: Xi, Nan Miles, et al.
Veröffentlicht: (2025)

Personalized Two-sided Dose Interval
von: Park, Chan, et al.
Veröffentlicht: (2023)

Statistics in Survey Sampling
von: Kim, Jae Kwang
Veröffentlicht: (2024)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
von: Zhu, Di, et al.
Veröffentlicht: (2026)

Sequential Design with Derived Win Statistics
von: Zhang, Baoshan, et al.
Veröffentlicht: (2024)

Randomness of Shapes and Statistical Inference on Shapes via the Smooth Euler Characteristic Transform
von: Meng, Kun, et al.
Veröffentlicht: (2022)

A Design and Analytic Strategy for Monitoring Disease Positivity and Case Characteristics in Accessible Closed Populations
von: Lyles, Robert H., et al.
Veröffentlicht: (2022)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
von: Yang, Peng, et al.
Veröffentlicht: (2026)

Two-dose vs. Three-Dose Optimization Under Sample Size Constraint
von: Sun, Linda, et al.
Veröffentlicht: (2026)

ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
von: Wang, Shuqi, et al.
Veröffentlicht: (2024)

Risk-inclusive Contextual Bandits for Early Phase Clinical Trials
von: Kanrar, Rohit, et al.
Veröffentlicht: (2025)

Synthetic Random Environmental Time Series Generation with Similarity Control, Preserving Original Signal's Statistical Characteristics
von: Aloni, Ofek, et al.
Veröffentlicht: (2025)

Semiparametric rank-based regression models as robust alternatives to parametric mean-based counterparts for censored responses under detection-limit
von: Xu, Y., et al.
Veröffentlicht: (2025)

U-DESPE: a Bayesian Utility-based methodology for dosing regimen optimization in early-phase oncology trials based on Dose-Exposure, Safety, Pharmacodynamics, Efficacy
von: Andrillon, Anaïs, et al.
Veröffentlicht: (2025)

Bridging the Gap Between Design and Analysis: Randomization Inference and Sensitivity Analysis for Matched Observational Studies with Treatment Doses
von: Zhang, Jeffrey, et al.
Veröffentlicht: (2024)

TWICEBEE: A Two-stage Intra-patient Curve-free Bayesian Decision-Theoretic Dose Escalation Design
von: Bi, Dehua, et al.
Veröffentlicht: (2026)